Gregory J. Mishkel, MD, FRCPC, FACC, FSCAI

TAVR and the Structural Heart Program at the Prairie Heart Institute

04/04/2016

Gregory J. Mishkel , MD, FRCPC, FACC, FSCAI;

The most remarkable and unique thing about our program is that it has been a fairly successful, robust, and innovative program in a city of relatively small size and in a non-academic institution with private practitioners.

The most remarkable and unique...

04/04/2016

Cath Lab Digest

A Practical Approach to Endovascular Therapy fr Infrapopliteal Disease and the Treatment of Critical Leg

06/19/2008

Nilesh J. Goswami , MD;

Gregory J. Mishkel , MD, FRCPC, FACC, FSCAI;

Interventional cardiologists have increasingly translated their coronary skills to the field of peripheral interventions. Patients with cardiovascular disease frequently have associated PVD. This places cardiologists at the vanguard of...

Interventional cardiologists...

06/19/2008

Cath Lab Digest

Feature

A Practical Approach to Endovascular Therapy fr Infrapopliteal Disease and the Treatment of Critical Leg

06/19/2008

Nilesh J. Goswami , MD;

Gregory J. Mishkel , MD, FRCPC, FACC, FSCAI;

Interventional cardiologists...

06/19/2008

Cath Lab Digest

Original Contribution

Short- and Long-Term Clinical Outcomes of Coronary Drug-
Eluting Stent Recipients Presenting with Chronic Renal Disease

08/01/2008

Stephen J. Markwell , MA, MS;

Joji J. Varghese , MD, FACC, FSCAI;

Frank Aguirre , MD;

Marc Shelton , MD;

Gregory J. Mishkel , MD, FRCPC, FACC, FSCAI;

Anna L. Moore , MPH;

Chronic renal disease (CRD) is a common health concern in wealthy countries, with approximately 20 million American adults currently affected.1 While the association between renal insufficiency and increased risk of adverse non-fatal and...

Chronic renal disease (CRD) is a...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Bivalirudin versus Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Drug-Eluting Stent Implantations in the Absence of Acute Myo

08/01/2008

Gregory J. Mishkel , MD, FRCPC, FACC, FSCAI;

Anna L. Moore , MPH;

Stephen J. Markwell , MA, MS;

Robert W. Ligon , MS;

Bare-metal stents (BMS) lower the risk of restenosis and the need for repeat coronary revascularization compared to balloon angioplasty alone.1 The introduction of drug-eluting stents (DES) has further markedly decreased angiographic...

Bare-metal stents (BMS) lower...

08/01/2008

Journal of Invasive Cardiology

Vascular Disease

A Practical Approach to Endovascular Therapy for Infrapopliteal Disease and the Treatment of Critical Leg Ischemia: Savage or Sa

08/01/2008

Gregory J. Mishkel , MD, FRCPC, FACC, FSCAI;

Nilesh J. Goswami , MD;

Interventional cardiologists...

08/01/2008

Journal of Invasive Cardiology